Home > Dermatology > Psoriasis registries yield important data about COVID-19

Psoriasis registries yield important data about COVID-19

Presented By
Dr Satveer Mahil, St John’s Institute of Dermatology, UK
Conference
WPPAC 2021
Shortly after COVID-19 was declared a pandemic, the PsoProtect registry was set up. The patient counterpart PsoProtectMe was launched at the beginning of May. These registries yielded interesting data to inform guidelines. “These efforts were initiated to address unmet needs in the pandemic,” Dr Satveer Mahil (St John’s Institute of Dermatology, UK) explained [1]. Psoriasis is a common, lifelong immune-mediated condition associated with long-term health conditions, including obesity and mental health issues. Early in the pandemic several risk factors were shown to be associated with COVID-19-related death, such as chronic liver disease and obesity [2]. “These factors are relevant to our patients with psoriasis,” said Dr Mahil. Moreover, the pathogenesis of psoriasis and COVID-19 show overlapping immune pathways [3]. Finally, psoriasis treatment affects the immune system. Thus, it was hypothesised that in the early stage of a SARS-CoV-2 infect...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on